Taftian A, Abedi N, Zolfi Gol A (2025) Emerging threats: multidrug resistance and clinical challenges of acinetobacter spp. in modern healthcare. Pers Med J. https://doi.org/10.22034/pmj.2025.2058093.1057
Sharma R, Lakhanpal D (2025) Acinetobacter baumannii: a comprehensive review of global epidemiology, clinical implications, host interactions, mechanisms of antimicrobial resistance and mitigation strategies. Microb Pathog 204:107605. https://doi.org/10.1016/j.micpath.2025.107605
Article PubMed CAS Google Scholar
Maitra R, Saxena D, Singh S, A A, Majumder A, Janani S, Dasgupta A, Chopra S (2025) Multidrug-resistant Acinetobacter baumannii: a wily, existential threat to modern healthcare. ACS Infect Dis 11:2951–2978. https://doi.org/10.1021/acsinfecdis.5c00570
Article PubMed CAS Google Scholar
Zhang S, Di L, Qi Y, Qian X, Wang S (2024) Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii. Front Cell Infect Microbiol 14:1395260. https://doi.org/10.3389/fcimb.2024.1395260
Article PubMed PubMed Central CAS Google Scholar
Dubey V, Reza N, Hope W (2025) Drug-resistant Acinetobacter baumannii: mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen. Clin Microbiol Rev 38:e00279-24. https://doi.org/10.1128/cmr.00279-24
Article PubMed PubMed Central CAS Google Scholar
Boutzoukas A, Doi Y (2025) The global epidemiology of carbapenem-resistant Acinetobacter baumannii. JAC-Antimicrob Resist 7:dlaf134. https://doi.org/10.1093/jacamr/dlaf134
Article PubMed PubMed Central Google Scholar
Zarrilli R, Giannouli M, Tomasone F, Triassi M, Tsakris A (2009) Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. J Infect Dev Ctries 3:335–341. https://doi.org/10.3855/jidc.240
Article PubMed CAS Google Scholar
Lodise TP, Nguyen ST, Margiotta C, Cai B (2025) Clinical burden of Acinetobacter baumannii, including carbapenem-resistant A. baumannii, in hospitalized adult patients in the USA between 2018 and 2022. BMC Infect Dis 25:549. https://doi.org/10.1186/s12879-025-10749-1
Article PubMed PubMed Central CAS Google Scholar
Sim HS, Kwon Y-K, Song H, Hwang G-S, Yeom J (2025) Regulation of antibiotic persistence and pathogenesis in Acinetobacter baumannii by glutamate and histidine metabolic pathways. BMC Microbiol 25:74. https://doi.org/10.1186/s12866-024-03654-1
Article PubMed PubMed Central CAS Google Scholar
Read BJ, Cadzow AF, Alphey MS, Mitchell JBO, Da Silva RG (2024) Crystal structure, steady-state, and pre-steady-state kinetics of Acinetobacter baumannii ATP phosphoribosyltransferase. Biochemistry 63:230–240. https://doi.org/10.1021/acs.biochem.3c00551
Article PubMed CAS Google Scholar
Read BJ, Fisher G, Wissett OL, Machado TF, Nicholson J, Mitchell JB, da Silva RG (2021) Allosteric inhibition of Acinetobacter baumannii ATP phosphoribosyltransferase by protein: dipeptide and protein: protein interactions. ACS Infect Dis 8:197–209
Read BJ, Fisher G, Wissett OLR, Machado TFG, Nicholson J, Mitchell JBO, Da Silva RG (2022) Allosteric inhibition of Acinetobacter baumannii ATP phosphoribosyltransferase by protein:dipeptide and protein:protein interactions. ACS Infect Dis 8:197–209. https://doi.org/10.1021/acsinfecdis.1c00539
Article PubMed CAS Google Scholar
Arshad N, Azzam W, Zilberberg MD, Shorr AF (2025) Acinetobacter baumannii complex infections: new treatment options in the antibiotic pipeline. Microorganisms 13:356. https://doi.org/10.3390/microorganisms13020356
Article PubMed PubMed Central CAS Google Scholar
Ahmad N, Sharma P, Sharma S, Singh TP (2023) Crystal structure of Adenosine triphosphate phosphoribosyltransferase from Acinetobacter baumannii at 2.18 A resolution
Berman HM (2000) The protein data bank. Nucleic Acids Res 28:235–242. https://doi.org/10.1093/nar/28.1.235
Article PubMed PubMed Central CAS Google Scholar
Burley SK, Bhatt R, Bhikadiya C, Bi C, Biester A, Biswas P, Bittrich S, Blaumann S, Brown R, Chao H (2025) Updated resources for exploring experimentally-determined PDB structures and computed structure models at the RCSB Protein Data Bank. Nucleic Acids Res 53:D564–D574
Article PubMed PubMed Central CAS Google Scholar
DeLano WL (2002) Pymol: an open-source molecular graphics tool. CCP4 Newsl Protein Crystallogr 40:82–92
Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. In: Hempel JE, Williams CH, Hong CC (eds) Chemical biology: methods and protocols. Springer, New York, pp 243–250
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:455–461
Article PubMed PubMed Central CAS Google Scholar
O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR (2011) Open Babel: an open chemical toolbox. J Cheminform 3:1–14
BIOVIA, Dassault Systèmes (2024) Discovery Studio Visualizer, San Diego
Ahmad N, Singh A, Gupta A, Pant P, Singh TP, Sharma S, Sharma P (2022) Discovery of the lead molecules targeting the first step of the histidine biosynthesis pathway of Acinetobacter baumannii. J Chem Inf Model 62:1744–1759. https://doi.org/10.1021/acs.jcim.1c01421
Article PubMed CAS Google Scholar
Yang C, Li J, Luo X, Song Z, Zhang J (2026) Therapeutic challenges and emerging strategies against carbapenem-resistant Acinetobacter baumannii. Curr Res Microb Sci 10:100581. https://doi.org/10.1016/j.crmicr.2026.100581
Article PubMed PubMed Central CAS Google Scholar
Singh A, Tanwar M, Singh TP, Sharma S, Sharma P (2025) Targeting histidine biosynthesis in Acinetobacter baumannii: structure-based discovery of natural inhibitors of ATP-phosphoribosyltransferase. Mol Divers. https://doi.org/10.1007/s11030-025-11409-x
Sleijfer S (2001) Bleomycin-induced pneumonitis. Chest 120:617–624. https://doi.org/10.1378/chest.120.2.617
Article PubMed CAS Google Scholar
Reinert T, Baldotto CSDR, Nunes FAP, Scheliga AADS (2013) Bleomycin-induced lung injury. J Cancer Res 2013:1–9. https://doi.org/10.1155/2013/480608
Comments (0)